Merola J, Conrad C, Foley P, Iversen L, Langley R, Kokolakis G, Davis L, Hoepken B, Dixon J, Warren R. Bimekizumab Versus Secukinumab Continuous Maintenance of PASI 90 and PASI 100 Responses through One Year in Patients with Moderate to Severe Plaque Psoriasis: Post-HOC Results from the BE RADIANT Phase 3b Trial. J of Skin [Internet]. 2024Mar.18 [cited 2024Oct.26];8(2):s403. Available from: https://skin.dermsquared.com/skin/article/view/2731